AcademiaAdvance research and accelerate real-world outcomes
Advance research and accelerate real-world outcomes
CorporateDrive innovation and build strong brands
Drive innovation and build strong brands
GovernmentMaximize the impact of your country’s research and innovation
Maximize the impact of your country’s research and innovation
Legal ServicesEvolve your practice and maximize growth potential
Evolve your practice and maximize growth potential
Life Sciences and HealthcareAdvance innovation and accelerate patient outcomes
Advance innovation and accelerate patient outcomes
Scientific & Academic Researcharrow_forward
Discovery & Workflow
Analytics, Evaluation & Management
Discovery, Clinical & Regulatory
Portfolio Strategy & Business Development
Commercial & Launch Strategy
Strategic Portfolio Planning
Product Lifecycle Management
IP Litigation Intelligence Solutions
Patent Intelligence Software
Patent Search & Analytics
Trademark Research & Protection
Chemistry & Life Science
IP Data & APIs
IP Lifecycle Managementarrow_forward
Patent & Trademark Management Software
Network Collaboration Tools
Patent & Trademark Maintenance
Filing & Prosecution Support
Patent Translations Services
Consulting & Dataarrow_forward
Research Intelligence Cloud
Real World Data
BlogKeep up with the latest news, insights and research from Clarivate.
Keep up with the latest news, insights and research from Clarivate.
Clarivate Innovation ExchangeThe Clarivate Innovation Exchange accelerates research, development and commercialization.
The Clarivate Innovation Exchange accelerates research, development and commercialization.
Partnersarrow_forwardPartner with us and help accelerate innovation.
Partner with us and help accelerate innovation.
Cortellis Partner Program
ScholarOne Partner Program
Researcher RecognitionWorld-changing research should be seen, shared and celebrated.
World-changing research should be seen, shared and celebrated.
Academic & Government
Life Sciences & Healthcare
Reports & Case Studiesarrow_forward
ISI Global Research Reports
PodcastsThe Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
The Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
Life Sciences and Healthcare
Scientific & Academic Research
IP Lifecycle Management
Consulting & Data
Clarivate Innovation Exchange
Reports & Case Studies
Diabetic Macular Edema
Patients with proliferative diabetic retinopathy (PDR) experience retinal damage that can eventually lead to debilitating vision deficits and blindness, especially with the development of diabetic…
Diabetic macular edema (DME) associated with diabetic retinopathy (DR) is a rapidly evolving market as a result of multiple intravitreal (IVT) pharmacotherapy approvals across different drug…
Diabetic macular edema (DME) represents the second-largest ophthalmology market for intravitreal anti-VEGF therapies, including Roche / Novartis’s Lucentis and Regeneron / Bayer’s market-…
The DR / DME therapy market will grow moderately over the forecast period (6.6% annual growth through 2029); this growth will be due largely to:
The launch of five new therapeutic options for…
Patients with diabetic retinopathy (DR) experience retinal damage that can lead to vision impairment and eventual blindness, especially with the development of diabetic macular edema (DME). DME…
As part of ongoing efforts to address the rising cost of pharmaceuticals, the U.S. Centers for Medicare & Medicaid Services significantly shifted policy to allow Medicare Advantage plans to impose…
DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key diabetic macular edema patient populations covering 171 countries and more…
The development of biosimilar versions of Lucentis and Eylea is of high interest in the ophthalmology market given the high cost of these agents, the large patient population suffering from retinal…
DRG Epidemiology’s coverage of diabetic macular edema (DME) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of DME for each…